Repros Therapeutics Inc. (Nasdaq: RPRX) announced that they have priced a 690,000 unit offering at $17.15 per ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE